메뉴 건너뛰기
Journal of Clinical Oncology
Volumn 26, Issue 29, 2008, Pages 4849-4850
Gefitinib maintenance in stage III non-small-cell lung cancer
Author keywords

[No Author keywords available]
Indexed keywords

GEFITINIB;
EID: 54249149068     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2008.18.7625     Document Type: Letter
Times cited : (3)
References (7)
  • 1
    • 45149102984 scopus 로고    scopus 로고
    • Phase III trial of maintenance gefitinib or placebo after concurrent chemoradiotherapy and docetaxel consolidation in inoperable stage III non-small-cell lung cancer: SWOG S0023
    • Kelly K, Chansky K, Gaspar LE, et al: Phase III trial of maintenance gefitinib or placebo after concurrent chemoradiotherapy and docetaxel consolidation in inoperable stage III non-small-cell lung cancer: SWOG S0023. J Clin Oncol 26:2450-2456, 2008
    • (2008) J Clin Oncol , vol.26 , pp. 2450-2456
    • Kelly, K.1    Chansky, K.2    Gaspar, L.E.3
  • 2
    • 45149099893 scopus 로고    scopus 로고
    • Does gefitinib shorten lung cancer survival? Chaos redux
    • Keedy VL, Arteaga CL, Johnson DH: Does gefitinib shorten lung cancer survival? Chaos redux. J Clin Oncol 26:2428-2430, 2008
    • (2008) J Clin Oncol , vol.26 , pp. 2428-2430
    • Keedy, V.L.1    Arteaga, C.L.2    Johnson, D.H.3
  • 3
    • 33847356079 scopus 로고    scopus 로고
    • Chemotherapy dose-response relationships in non-small cell lung cancer and implied resistance mechanisms
    • Stewart DJ, Chiritescu G, Dahrouge S, et al: Chemotherapy dose-response relationships in non-small cell lung cancer and implied resistance mechanisms. Cancer Treat Rev 33:101-137, 2007
    • (2007) Cancer Treat Rev , vol.33 , pp. 101-137
    • Stewart, D.J.1    Chiritescu, G.2    Dahrouge, S.3
  • 4
    • 5344225602 scopus 로고    scopus 로고
    • A pleiotropic defect reducing drug accumulation in cisplatin-resistant cells
    • Liang XJ, Shen DW, Gottesman MM: A pleiotropic defect reducing drug accumulation in cisplatin-resistant cells. J Inorg Biochem 98:1599-1606, 2004
    • (2004) J Inorg Biochem , vol.98 , pp. 1599-1606
    • Liang, X.J.1    Shen, D.W.2    Gottesman, M.M.3
  • 5
    • 84871471909 scopus 로고    scopus 로고
    • Tumor CTR1 copper transporter modulation by decitabine (DAC) and relationship to global DNA methylation and time from prior therapy
    • abstr
    • Stewart DJ, Nunez M, Jelinek J, et al: Tumor CTR1 copper transporter modulation by decitabine (DAC) and relationship to global DNA methylation and time from prior therapy. Proc Am Soc Med Oncol 26:11088, 2008 (abstr)
    • (2008) Proc Am Soc Med Oncol , vol.26 , pp. 11088
    • Stewart, D.J.1    Nunez, M.2    Jelinek, J.3
  • 6
    • 24944440830 scopus 로고    scopus 로고
    • TRIBUTE: A phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung cancer
    • Herbst RS, Prager D, Hermann R, et al: TRIBUTE: A phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung cancer. J Clin Oncol 23:5892-5899, 2005
    • (2005) J Clin Oncol , vol.23 , pp. 5892-5899
    • Herbst, R.S.1    Prager, D.2    Hermann, R.3
  • 7
    • 84871473110 scopus 로고    scopus 로고
    • Stewart DJ: Preliminary assessments using nonlinear regression analysis of semilog survival curve plots to detect and characterize prognostically distinct subgroups in non-small cell lung cancer patients treated with epidermal growth factor receptor tyrosine kinase inhibitors. 12th World Congress on Lung Cancer, Seoul, South Korea, September 2-6, 2007 (abstr C1-02)
    • Stewart DJ: Preliminary assessments using nonlinear regression analysis of semilog survival curve plots to detect and characterize prognostically distinct subgroups in non-small cell lung cancer patients treated with epidermal growth factor receptor tyrosine kinase inhibitors. 12th World Congress on Lung Cancer, Seoul, South Korea, September 2-6, 2007 (abstr C1-02)

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.